Sort
39,280 grants matching “leukemia”
HVEM-BTLA Pathway in Lymphoma
$392,486Carl F Ware · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Off-the-shelf iPSC-Derived Natural Killer Cell Immunotherapies for AML
$392,480Jeffrey S Miller · University Of Minnesota · P01 · FY2025 · CA
Role of DNA sensors in host anti-retroviral defense
$392,454Susan R Ross · University Of Illinois At Chicago · R01 · FY2020 · AI
Role of DNA sensors in host anti-retroviral defense
$392,454Susan R Ross · University Of Illinois At Chicago · R01 · FY2017 · AI
Role of DNA sensors in host anti-retroviral defense
$392,454Susan R Ross · University Of Illinois At Chicago · R01 · FY2018 · AI
Role of DNA sensors in host anti-retroviral defense
$392,454Susan R Ross · University Of Illinois At Chicago · R01 · FY2019 · AI
Role of DNA sensors in host anti-retroviral defense
$392,434Susan R Ross · University Of Illinois At Chicago · R01 · FY2016 · AI
TRANSPORT OF PROTEINS IN AND OUT OF THE NUCLEUS
$392,430Dana-Farber Cancer Institute · R01 · FY2002 · GM
Dissection of Pten-regulated signals in hepatopathogenesis
$392,425Gen-Sheng Feng · University Of California, San Diego · R01 · FY2019 · CA
Targeting blastic plasmacytoid dendritic cell neoplasm (BPDCN)
$392,412Andrew A Lane · Dana-Farber Cancer Inst · R37 · FY2023 · CA
Modeling pediatric glioma in human ES cells:mechanistic and therapeutic insights
$392,390Viviane Tabar · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Potential therapeutic implications of targeting miR-150 in acute myeloid leukemia
$392,355Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Redefining the major peanut allergens
$392,212Stephen C. Dreskin · University Of Colorado Denver · R01 · FY2010 · AI
In vivo Prevention of Murine GVHD
$392,198Bruce R. Blazar · University Of Minnesota · R01 · FY2012 · AI
SOLID STATE RADIATION CHEMISTRY OF DNA
$392,193University Of Rochester · R01 · FY2001 · CA
Functions of JARID2 in Normal and Neoplastic Hematopoiesis
$392,187Grant Anthony Challen · Washington University · R01 · FY2019 · HL
PD-L1 interacts with CD80 and PD-1 to regulate GVHD and GVL activity
$392,146Defu Zeng · Beckman Research Institute/City Of Hope · R01 · FY2019 · CA
Research in the Pathogenesis of Hematologic Disorders
$392,053Lawrence Benjamin Gardner · New York University School Of Medicine · T32 · FY2015 · HL
Gene Therapy for Retinitis Pigmentosa
$392,040Rajendra Kumar-Singh · Tufts University Boston · R01 · FY2011 · EY
Gene and Cytokine Expression in Tolerance and GVHD
$392,040Samuel Strober · Stanford University · R01 · FY2012 · AI
Gene and Cytokine Expression in Tolerance and GVHD
$392,040Samuel Strober · Stanford University · R01 · FY2011 · AI
Gene Therapy for Retinitis Pigmentosa
$392,040Rajendra Kumar-Singh · Tufts University Boston · R01 · FY2012 · EY
Spatiotemporal Dynamics of the Genome by 3D Orbital Tracking
$392,031Matthew Lee Ferguson · Boise State University · R15 · FY2022 · GM
Yes1 as a quiescence regulator in hematopoietic stem cells
$392,000Siddhartha Mukherjee · Columbia University Health Sciences · R01 · FY2014 · HL
DC-ASGPR as Novel Target for Controlling GVHD and Allograft Rejection
$392,000Sangkon Oh · Baylor Research Institute · R01 · FY2017 · AI